ArticlePharmacology research & perspectives2020
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab.
Stefan Schreiber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it